Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. (Q45175176)

10 December 2017

title

Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. (English)

1 reference

10 December 2017

0 references

6

1 reference

10 December 2017

François Mailliet

1

1 reference

10 December 2017

Gilles Ferry

2

1 reference

10 December 2017

Fanny Vella

3

1 reference

10 December 2017

Kader Thiam

4

1 reference

10 December 2017

Philippe Delagrange

5

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

578

1 reference

10 December 2017

issue

1-2

1 reference

10 December 2017

page(s)

116-120

1 reference

Therapeutic perspectives for melatonin agonists and antagonists.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Melatonin receptors: localization, molecular pharmacology and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 .

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Kinetic and docking studies of the interaction of quinones with the quinone reductase active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

Free-running activity rhythms in the rat: entrainment by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.10.083

10.1016/J.FEBSLET.2004.10.083

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference